A Phase II, randomized, double blind, parallel group,46 weeks dose-finding study of BI 456906 administered once weekly subcutaneously compared with placebo in patients with obesity or overweight
Details
Age
Adult
Type of Study
Treatment
Locations
Anschutz Health and Wellness
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 21-2824
More information available at ClinicalTrials.gov: NCT04667377
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers